As global investors grow jittery over U.S. trade volatility, they're quietly rotating <a href="https://www.benzinga.com/topic/japan">capital into Japan</a>—powering a stealthy "Ninja Rally" that's outpacing Wall Street's swagger. Meanwhile, Bridgewater's complete exit from U.S.-listed Chinese stocks adds urgency to this eastward move.



<ul class="wp-block-list">
<li>Keep a watch on U.S. equity tracking SPY <a href="https://www.benzinga.com/quote/SPY">here</a>.</li>
</ul>



<h3 class="wp-block-heading">Money Slips East as Japan Steals the Show</h3>



Investors from Asia and the Middle East are dialing back U.S. exposure amid rising tariff uncertainty and policy turbulence. Partners Group <a href="https://www.ft.com/content/cdc46563-d04d-45e2-bfab-e0a85287456b">says</a> some clients—even sovereign funds—are demanding euro-denominated accounts and non-U.S. custodians "in case it all goes crazy," citing fears of financial fragmentation under the current U.S. administration. Investors are deliberately dialing down U.S. exposure, spooked by policy zigzags <a href="https://www.benzinga.com/topic/tariffs">and tariff risks</a>.



The move signals growing fears over U.S. stability and could fragment the global financial system.



<h3 class="wp-block-heading">Bridgewater Exits China, Adds Fuel to the Rally</h3>



The trend isn't limited to regional players. In a bold pivot, Bridgewater Associates— once a stalwart in China equity investing — has completely <a href="https://asia.nikkei.com/business/markets/equities/bridgewater-cuts-china-exposure-selling-all-1.4bn-in-shares">offloaded</a> its entire U.S.-listed China equity portfolio—about $1.4 billion across 16 stocks including Alibaba Group Holding Ltd (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BABA#NYSE">BABA</a>) (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BABAF#NYSE">BABAF</a>), JD.com Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JD#NASDAQ">JD</a>) and Baidu Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIDU#NASDAQ">BIDU</a>) and Nio Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NIO#NYSE">NIO</a>). The move signals rising investor caution and underscores Japan's newfound appeal as a safer, more stable alternative.



Read Also: <a href="https://www.benzinga.com/etfs/specialty-etfs/25/02/43938543/buffetts-japan-play-why-investors-shouldnt-sleep-on-these-stocks-etfs">Buffett&#8217;s Japan Play: Why Investors Shouldn&#8217;t Sleep On These Stocks, ETFs</a>



<h3 class="wp-block-heading">The ‘Ninja Rally' Goes Mainstream</h3>



While U.S. markets wobble, Japan is on a stealth boom. Since early April's "liberation day" tariff headlines, foreign investors have been net buyers, propelling the TOPIX to record highs before a modest pullback. 



Analysts say this rally differs from 2024's exporter-led surge: now, foreign funds, domestic institutions, and retail investors are all engaged, helped by governance reforms and a U.S.-Japan trade deal that was less severe than expected.



<h2 class="wp-block-heading">Scoreboard: Japan Vs. U.S.</h2>



The gap shows in U.S.-listed ETFs: As of Sept. 2, the SPDR S&amp;P 500 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) is up 9.02% YTD, while the Invesco QQQ ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>) 10.39%.



<ul class="wp-block-list">
<li>Japanese equity tracking iShares MSCI Japan ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EWJ#NYSE">EWJ</a>) is ahead at 16.30%</li>



<li>The WisdomTree Japan Hedged Equity Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DXJ#NYSE">DXJ</a>) has delivered around 13.69%</li>



<li>JPMorgan BetaBuilders Japan ETF (BATS:<a class="ticker" href="https://www.benzinga.com/stock/BBJP#BATS">BBJP</a>) sits at 17.54% gains.</li>
</ul>



<h3 class="wp-block-heading">Stock Snapshots Investors Care About</h3>



U.S. megacaps are mixed: 



<ul class="wp-block-list">
<li>Nvidia Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) is up 22.53% YTD</li>



<li>Tesla Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) is down 13%, and </li>



<li>Apple Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) is down 6.11%.</li>
</ul>



Japan-linked U.S. listings are stronger: 



<ul class="wp-block-list">
<li>Sony Group Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SONY#NYSE">SONY</a>) is up 27.81%</li>



<li>Mitsubishi UFJ Financial Group Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MUFG#NYSE">MUFG</a>) banks are guiding for record profits (stock up 22.31%), and </li>



<li>Toyota Motor Corp's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TM#NYSE">TM</a>) U.S. ADR, up just 0.04%.</li>
</ul>



<h3 class="wp-block-heading">Why It Matters</h3>



Global allocators reducing U.S. exposure and favoring Japan could keep pushing Japanese equities higher, especially in currency-hedged ETFs and financial stocks tied to rising JGB yields. 



For U.S.-focused portfolios, this is a signal to stress-test home bias, track trade headlines, and consider whether Japan's stealth rally is a tactical trade—or a structural shift.



Read Next: 



<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/etfs/emerging-market-etfs/25/07/46577333/trade-war-or-trade-win-the-curious-case-of-surging-japan-etfs">Trade War Or Trade Win? The Curious Case Of Surging Japan ETFs</a></li>
</ul>



Image: Shutterstock

The 'Ninja Rally' Is Real—And It's Stealing Wall Street's Swagger

Palo Alto Networks (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PANW#NASDAQ">PANW</a>) <a href="https://www.benzinga.com/topic/cybersecurity" target="_blank" rel="noreferrer noopener">confirmed a data breach</a> after attackers used stolen OAuth tokens from the Salesloft Drift compromise to access its Salesforce Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRM#NYSE">CRM</a>) system.



PANW is trading near recent highs. <a href="https://www.benzinga.com/quote/PANW" target="_blank" rel="noreferrer noopener">See what is driving the move here.</a>



The attackers exfiltrated business contact details, sales records and support case comments but did not compromise any products, services, or internal systems.



The breach was part of a larger supply-chain campaign, tracked by Google&#8217;s Threat Intelligence team as UNC6395, that targeted Salesforce environments to steal sensitive credentials like Amazon.com Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) Amazon Web Services keys, VPN logins and Snowflake (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNOW#NYSE">SNOW</a>) tokens, Bleeping Computer <a href="https://www.bleepingcomputer.com/news/security/palo-alto-networks-data-breach-exposes-customer-info-support-cases/" target="_blank" rel="noreferrer noopener">reported</a> on Tuesday.



Also Read: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/05/45551481/palo-altos-ai-momentum-make-it-a-top-cybersecurity-pick-analyst-says" target="_blank" rel="noreferrer noopener">Palo Alto&#8217;s AI Momentum Make It A Top Cybersecurity Pick, Analyst Says</a>



Benzinga contacted Palo Alto Networks&#8217; investor team for their take on the report and is awaiting a response.



Attackers used custom Python tools, Tor for obfuscation and log deletion techniques to evade detection.



Palo Alto Networks revoked tokens, rotated credentials and disabled the Drift integration, urging all affected companies to investigate logs, audit integrations, and rotate secrets immediately.



The Salesloft attack has impacted several major organizations, including Alphabet Inc.&#8217;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) Google, Zscaler (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZS#NASDAQ">ZS</a>), Cisco Systems Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSCO#NASDAQ">CSCO</a>), and Adidas. It marks a significant escalation in Salesforce data theft campaigns linked to ShinyHunters tactics.



<h2 class="wp-block-heading">What Do Analysts Think of Palo Alto Networks Stock?</h2>



Palo Alto Networks&#8217; stock gained almost 5% year-to-date. Wall Street analysts <a href="https://www.benzinga.com/analyst-stock-ratings/reiteration/25/08/47219340/palo-alto-stock-pops-as-analysts-say-strong-growth-cyberark-deal-could-power-next-leg-higher" target="_blank" rel="noreferrer noopener">reaffirmed bullish views</a> on the company after it beat fourth-quarter estimates and issued strong guidance. 



Rosenblatt&#8217;s Catharine Trebnick, BMO&#8217;s Keith Bachman and Truist&#8217;s Junaid Siddiqui raised price targets, citing strength in next-gen security ARR, platform momentum and a clear path to $15 billion ARR. Scotiabank&#8217;s Patrick Colville called Palo Alto one of software&#8217;s best long-term cybersecurity stories.



Guggenheim&#8217;s John DiFucci raised his forecast but kept a Sell, warning RPO duration clouds growth visibility, while Stephens and Raymond James stayed Neutral. Most firms, including Goldman Sachs, Piper Sandler and RBC Capital, maintained Buy or Outperform ratings, highlighting record RPO, margin expansion and resilient demand for cybersecurity. <a href="https://www.benzinga.com/quote/PANW/analyst-ratings">Today,</a> Morgan Stanley maintained an Overweight rating and raised the price target to $216.



PANW Price Action: Palo Alto Networks is trading down 0.28% at $189.98 at publication on Tuesday.



Read Next:



<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/analyst-stock-ratings/reiteration/25/08/47419007/marvell-stock-plunges-as-wall-street-warns-of-limited-near-term-growth-prospects" target="_blank" rel="noreferrer noopener">Marvell Stock Plunges As Wall Street Warns Of Limited Near-Term Growth Prospects</a></li>
</ul>



Photo: Shutterstock

Palo Alto Investigates Data Theft After Hackers Exploit Stolen OAuth Tokens

The ETF boom has hit a milestone that feels more like a plot twist in the current market environment. For the first time ever, there are now more U.S.-listed exchange-traded funds than actual U.S.-listed stocks. The latest <a href="https://www.benzinga.com/etfs">ETF gold rush</a> brought the number to 4,300, compared to around 4,200 companies.



In 2025 alone, issuers have launched more than 640 new ETFs—about four per day. A decade ago ETFs accounted for less than 10% of the investment universe; now they make up roughly a quarter.



What started as a low-cost alternative to mutual funds has exploded into a supermarket of niche ideas, ranging from AI-themed portfolios to cannabis plays to ETFs that sound like The Onion made them up.



"Choice is great until it becomes a burden," Douglas Boneparth of Bone Fide Wealth said <a href="https://www.bloomberg.com/news/articles/2025-08-25/us-etfs-eclipse-total-number-of-stocks-in-paradox-of-choice-for-investors">per</a> Bloomberg.



"There's an ETF for everything now — AI, pets, cannabis, woke and anti-woke portfolios. It's hard to tell whether you're investing in something meaningful for the long term or you're filling out an online quiz for Buzzfeed," he noted.



For investors, the explosion is both empowering and overwhelming. Sure, costs are down and access is broader than ever, but sifting through endless acronyms with nearly identical tickers is another story. It's like walking into a supermarket with 47 brands of bottled water—you end up wondering why you came in at all.



<h3 class="wp-block-heading">Tail Wagging The Dog</h3>



ETFs were supposed to simplify investing: one product, diversified exposure, low fees. But popularity can distort purpose. The fact that the number of funds now exceeds the number of actual companies is, frankly, unnatural. It's the tail wagging the dog.



The first ETFs, dating back to the 1990s, tracked broad indexes such as the S&amp;P 500. Then came sector funds, country funds, bond funds, and eventually the flood of single-stock leveraged products that look more like casino chips than retirement tools. Investors wanted more, issuers obliged, and now we're at the point where product proliferation is starting to create systemic risk.



More ETFs chasing the same pool of underlying assets means that, in a sharp sell-off, liquidity could vanish in ways the market hasn't thoroughly tested. Although ETFs promise daily tradability, the illusion of liquidity depends on market makers and the healthy functioning of the underlying cash markets. If that cracks, ETFs could amplify stress rather than absorb it.



<h3 class="wp-block-heading">Institutions Remain Optimistic</h3>



Still, Wall Street isn't ready to call the peak of ETFs. Morgan Stanley's Global Head of Capital Markets and ETF Strategy, Ally Wallace, argues that active ETFs, in particular, are built for resilience—even in downturns.



"The last five years have shown that fixed income ETFs, especially actively managed ones, thrive because of their three Ts—tax efficiency, transparency, and tradability," Wallace said in a recent <a href="https://www.morganstanley.com/im/en-us/individual-investor/insights/articles/active-etfs-may-thrive-even-in-down-markets.html">note</a>.



She noted that the adoption of <a href="https://www.sec.gov/newsroom/press-releases/2019-190">SEC Rule 6c-11</a> in 2019 opened the floodgates for innovation, and the appetite hasn't slowed since. For her, the case for active ETFs is simple: investors want the liquidity and tax perks of ETFs, but also the professional oversight of an active manager.



"Even in down markets, investors recognize the efficiency of the ETF wrapper. That's not a fad, that's a structural shift," she concluded.



Price Watch: The AdvisorShares Vice ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VICE#NYSE">VICE</a>), which invests in the products and services that people find pleasure in regardless of economic conditions, is up 14.22% year-to-date.



Read Next: 



<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/equities/25/09/47441669/bofas-risk-love-indicator-hits-13-month-high-market-sentiment-is-through-the-roof">BofA&#8217;s Risk-Love Indicator Hits 13-Month High — &#8216;Market Sentiment Is Through The Roof&#8217;</a></li>
</ul>



Image: Shutterstock

ETFs Just Outnumbered Stocks—The Tail Officially Wags The Dog

U.S. manufacturing <a href="https://www.benzinga.com/news/politics/25/09/47452441/trump-tariffs-manufacturing-pmi-ism-activity-prices">contracted for a sixth consecutive month in August</a>, with the ISM manufacturing purchasing managers index (PMI) easing back to 48.7 from 48.0 in July, indicating continued weakness in traditional industrial activity. 



Tariffs and sluggish demand continue to weigh on output, pressuring employment and production. The PMI's production index slipped to 47.8, and firms continue to trim headcounts amid subdued sentiment.



But through the gloom, there is a strong countertrend building: companies are increasing investments in AI gear and intellectual property, the quickest such rate in four years. That is coming through in the ISM new orders sub-index, which climbed to 51.4, at last breaking into expansionary territory after six months of decline. The divergence signals a subdued but increasing movement towards factory overhauls and automation.



Read Next: <a href="https://www.benzinga.com/markets/equities/25/09/47455549/market-today-wallstreet-tuesday-gold-vix-nvidia-bitcoin-performance">VIX Jumps 20% As Stocks Slump, Gold Tops Record Highs: What&#8217;s Moving Markets Tuesday?</a>



This split is already unfolding in the <a href="https://www.benzinga.com/etfs">ETF market</a>:



Traditional industrial ETFs, including the Industrial Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLI#NYSE">XLI</a>), are still struggling, reflecting the declining performance of old manufacturing. The fund is down 1.5% on Tuesday.



Even while U.S. manufacturing languishes in contraction, firms are investing heavily in artificial intelligence products, serving as a buffer against tariffs, Reuters reported. 



That pivot can drive investor interest toward AI- and automation-themed ETFs that aim to capture the capital pouring into faster, more intelligent factory floors. Highlights include:



Global X Robotics &amp; Artificial Intelligence ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BOTZ#NASDAQ">BOTZ</a>) — explores companies constructing industrial robots and AI-powered production platforms. 40% of its holdings are focused on the Industrials sector.



ROBO Global Robotics &amp; Automation ETF (ROBO) — a wide basket of automation pioneers, ranging from chip makers to factory-software masters. 21% of its holdings are focused on Manufacturing &amp; Industrial Automation.



Combined, these funds offer investors an opportunity to play the manufacturing upgrade cycle without investing in one company, and without being exposed to the slower-moving segments of the industrial economy.



Economists are anticipating this AI-spending-capital trend to persist, especially during more favorable tax incentives such as accelerated depreciation following <a href="https://www.benzinga.com/topic/donald-trump">the Trump administration&#8217;s</a> tax and spending bill, according to Reuters. While businesses caution that sustained tariff pressures, despite delayed passthrough, may ultimately transfer higher input costs to consumers, economists expect more investment in AI to occur in the near future.



The industrial base continues to be weak. But the increase in new orders fueled by AI-capital investment implies that the next industrial growth cycle will be less steel and assembly line driven and more semiconductor and robotics driven. ETFs such as BOTZ, and ROBO may provide the smoothest route to profit from that trend.



Read Next: 



<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/market-summary/25/09/47438659/sp500-september-seasonality-worst-stocks">Why Traders Fear September: 10 S&amp;P 500 Stocks To Watch As Weak Seasonality Kicks In</a></li>
</ul>



Photo: Shutterstock

Factory Slowdown Meets AI Frenzy: ETFs Caught Between Old Steel And New Silicon

Rocket Lab Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RKLB#NASDAQ">RKLB</a>) announced the opening of Launch Complex 3 and President Donald Trump said that he will move the headquarters of<a href="https://www.benzinga.com/news/space/25/08/47430367/ula-once-dismissed-elon-musks-approach-to-space-travel-now-spacex-has-launched-the-same-reusable-rocket-30-times"> U.S. Space Command.&nbsp;</a>



Here's a look at what's going on in<a href="https://www.benzinga.com/trading-ideas/movers/25/08/47310042/space-stock-tracker-rocket-lab-launches-starlink-outages"> the space sector.</a>&nbsp;



<ul class="wp-block-list">
<li>RKLB stock is down Tuesday. <a href="https://www.benzinga.com/quote/RKLB">Check out the real-time price action here. </a></li>
</ul>



<h2 class="wp-block-heading">Rocket Lab &#8211; RKLB</h2>



Last week, Rocket Lab opened its Launch Complex 3 at the Mid-Atlantic Regional Spaceport (MARS) in Virginia, managed by the Virginia Spaceport Authority.&nbsp;



Read Next:<a href="https://www.benzinga.com/markets/large-cap/25/09/47439374/nextera-energy-eyes-a-nuclear-revival?utm_source=articleShare"> NextEra Energy Eyes A Nuclear Revival&nbsp;</a>



The new complex is Rocket Lab's fourth launch site and includes advanced infrastructure such as a 30-foot-tall launch mount and 180,000-gallon LOX and LNG propellant farms.&nbsp;



The facility will be instrumental in the development of Rocket Lab's Neutron reusable rocket, which is designed to launch payloads of up to 33,000 pounds into space.



The Neutron rocket will support commercial satellite constellations, security applications, interplanetary missions and human spaceflight, according to Rocket Lab.&nbsp;



<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"><div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Launch Complex 3 is officially open for business! LC-3 pad activation is a critical milestone on the path to Neutron&#39;s first launch, and a bold step forward in delivering assured access to space for the USA&#39;s most important missions&#x1f680; Thank you <a href="https://twitter.com/GovernorVA?ref_src=twsrc%5Etfw">@GovernorVA</a> Glenn Youngkin,… <a href="https://t.co/BhjzKQOr4b">pic.twitter.com/BhjzKQOr4b</a>&mdash; Rocket Lab (@RocketLab) <a href="https://twitter.com/RocketLab/status/1961163772837442008?ref_src=twsrc%5Etfw">August 28, 2025</a></blockquote><script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script>
</div></figure>



Rocket Lab stock was trading around $47.30 per share on Tuesday, after gaining more than 130% over the past six months.&nbsp;



<h2 class="wp-block-heading">Intuitive Machines &#8211; LUNR&nbsp;</h2>



Intuitive Machines, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LUNR#NASDAQ">LUNR</a>) had another quiet week and the stock is down by nearly 20% after its <a href="https://www.benzinga.com/trading-ideas/movers/25/08/47120933/whats-going-on-with-intuitive-machines-stock-thursday">mid-August offering </a>of $300 million of 2.5% convertible senior notes.&nbsp;



<h2 class="wp-block-heading">AST SpaceMobile &#8211; ASTS&nbsp;</h2>



AST SpaceMobile, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASTS#NASDAQ">ASTS</a>) shares were mostly flat over the past week and down nearly 5% over the past month, according to data from<a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw"> Benzinga Pro</a>.&nbsp;



Read Next: <a href="https://www.benzinga.com/news/politics/25/09/47438150/trump-wants-americas-own-sovereign-wealth-fund-but-what-is-it-anyway?utm_source=articleShare">Trump Wants America&#8217;s Own Sovereign Wealth Fund — But What Is It Anyway?&nbsp;</a>



<h2 class="wp-block-heading">Starlink &#8211; SpaceX, Project Kuiper &#8211; AMZN&nbsp;</h2>



Starlink, the satellite internet provider run by Elon Musk&#8216;s SpaceX, was awarded $119 million by Montana to improve connectivity for over 20,000 locations in the state.&nbsp;



The funding is part of the U.S. Broadband Equity, Access and Deployment (BEAD) Program and allows Starlink to serve 28% of Montana&#8217;s 70,000 targeted locations.&nbsp;



Project Kuiper, part of Amazon.com Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>), was allotted access to 37% of the Montana&nbsp; locations, with $26 million in federal funding.&nbsp;



Montana&#8217;s BEAD Program chose to serve 65% of its designated locations with satellite internet instead of fiber optic installations.&nbsp;



<h2 class="wp-block-heading">Trump Moves Space Command</h2>



President Donald Trump announced on Tuesday that he will move<a href="https://www.politico.com/news/2025/09/02/trump-space-command-alabama-00539888"> the headquarters</a> of U.S. Space Command from Colorado Springs, Colorado, to Huntsville, Alabama, reversing a Biden-era decision that kept the command at its temporary base in Colorado.



Huntsville is also known as &#8220;Rocket City&#8221; and hosts the Army's Redstone Arsenal and NASA's Marshall Space Flight Center.&nbsp;



Space Command holds significant economic and strategic value and is responsible for satellite navigation, troop communication and missile launch alerts.&nbsp;



Read Next:&nbsp;



<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/politics/25/08/47364674/could-trump-target-a-stake-in-unitedhealth-next-maybe-heres-why?utm_source=articleShare">Could Trump Target A Stake In UnitedHealth Next? Maybe … Here&#8217;s Why</a></li>
</ul>



Photo: Shutterstock

Space Stock Tracker: Trump Moves Space Command, Rocket Lab Opens Launch Complex 3

By now those of you (hopefully this is all of you) that are regular readers of Under the Radar are aware of (at least) three things.



I look for stocks and opportunities that Wall Street is not following, and Instant Experts of the Internet have not yet discovered.



The fewer times it has been mentioned on social media that more likely I am to be interested.



Second, I am a hug fan of dividends.



While they may be out of favor at this money of time, at least in the United States over the last 100 years half the market long term returns have come from dividends.



Unlike hot stocks at thigh prices, dividends cannot be removed from your wallet by a market decline.



Dividends also provide a nice cushion when prices are falling. By now you should know that you cannot do anything about day-to-day market fluctuations.



You can make sure you own quality companies that constantly send cash into your account.



Finally, I am a cheap skate. I read Ben Graham and Marty Whitman very early in my career and the lessons have stocks with me.



Cheap, high yield stocks with a strong history of dividend payments that Wall Street is not following are close to the stock market equivalent of an uncontested layup.



It has worked very well for me (and my readers) for an exceptionally long time.



You should also know that with I will buy stocks that pass my tests form no matter where they are located.



Right now, despite countless suggestions from some of the world's smartest investors, most US based investors are just ignoring European markets.



European stocks today offer a better value proposition than their U.S. counterparts. Valuations in Europe remain deeply discounted relative to history and relative to the United States, with many high-quality companies trading below book value and offering attractive dividend yields.



The United States equity market is dominated by a handful of mega-cap technology names that have pushed valuations to historically stretched levels. Europe provides investors with solid businesses that have strong balance sheets, global revenue exposure, and lower valuations, meaning investors can buy quality earnings at a discount.



Beyond valuation, Europe is also offering income. Dividend yields on European equities are double those of U.S. stocks, and payout ratios remain sustainable.



This makes Europe attractive not only for value investors but also for income-oriented strategies seeking consistent cash flow.



Meanwhile, central banks in Europe are moving toward easing as inflation trends lower, providing a tailwind for equities. In contrast, the Federal Reserve remains in a tug-of-war with sticky inflation data, keeping U.S. policy uncertainty higher.



When you combine cheaper entry points, stronger income streams, and a potentially friendlier monetary policy environment, Europe stands out as the more compelling buy for investors positioning capital today.



Here are three overlooked European companies with solid dividend yields trading at bargain basement prices:



Aperam (Ticker: APEMY) Aperam, the Luxembourg-based stainless-steel producer spun out of ArcelorMittal, has carved out a reputation as one of Europe's most disciplined operators in a notoriously cyclical business. The company's mills span across Europe and South America, with a commercial presence in over forty countries, giving it both scale and reach.



Aperam's portfolio is focused on stainless, electrical, and specialty steels, products that tend to command more stable pricing power than commodity sheet steel. In recent years, management has placed heavy emphasis on energy efficiency, recycling, and high-value alloys, a strategic tilt that makes the business less exposed to the brutal price swings of standard steel.



From a valuation standpoint, the stock is compelling. Aperam trades at about 0.8 times book value, a discount to global peers and well below the level that would normally reflect the cash-generation ability of its operations.



Earnings are cyclical, but book value captures the underlying replacement cost of a well-invested plant base, and buying below book has historically been a recipe for outsized long-term returns in metals. The company's commitment to returning capital through dividends adds to the case. Investors are currently receiving an annual payout of $2.09 per ADR, which works out to a yield north of 6.5%, covered at about two-thirds of earnings.



For income-oriented value investors, it is hard to argue with buying a global steel champion at less than book and locking in a mid-single digit yield while waiting for the next upcycle.



Land Securities Group (Ticker: LDSCY) Land Securities is one of the United Kingdom's leading real estate investment trusts, with a portfolio that includes prime office buildings in London, retail centers across the country, and mixed-use developments that reflect the evolution of modern urban property markets. Its flagship assets, such as Nova in Victoria and Bluewater in Kent, are not just properties but destinations.



The company has also been rotating capital into more resilient sectors, such as mixed-use campuses and London's high-end office market, while disposing of non-core assets to sharpen its focus. This is not just another property landlord; Landsec is actively shaping the real estate landscape in one of the world's most dynamic cities.



Valuation tells the story here. Shares of LDSCY trade at about 0.7 times book value, a steep discount to the underlying net asset value of the properties. Historically, buying high-quality U.K. REITs at significant discounts to book has proven to be a patient investor's best friend, as markets eventually close that gap when conditions normalize.



The discount is particularly striking given that Landsec's balance sheet is solid, with moderate leverage and long-dated debt maturities. Investors are being paid handsomely to wait: the current dividend yield is in the range of 6 to 7%, with a payout ratio of about three-quarters of earnings.



That is a rich income stream supported by trophy assets that will remain in demand regardless of short-term market noise. For anyone who likes collecting rent checks from London's best properties without paying full price, Land Securities is a textbook buy.



TORM plc (Ticker: TRMD) TORM is a Danish shipping company with a long history in the refined product tanker market. Its fleet of more than ninety modern tankers transports gasoline, jet fuel, diesel, and other refined petroleum products around the globe.



This is a business that lives and dies by day rates, and TORM has benefited enormously from the post-pandemic dislocation in global energy logistics, where sanctions, supply bottlenecks, and shifting trade flows have combined to keep product tanker rates elevated. The company's operating leverage is enormous: a small increase in daily time-charter equivalent rates flows directly into free cash flow, which management has chosen to funnel back to shareholders through generous dividends.



The valuation remains undemanding given the balance sheet strength. TORM trades at about 1.1 times book value, a modest premium for a shipping company during one of the strongest earnings environments in decades. The book value reflects a modern fleet carried at conservative valuations, meaning the real market value of its vessels exceeds reported equity.



With a strong liquidity position and low net leverage, that premium to book is more than justified. On the income side, TORM is a monster. The annualized dividend yield sits at 13%, with payouts flexing up and down in line with quarterly earnings. Investors have already collected multiple dollars per share this year, and the distribution policy ensures that when the market is strong, cash goes straight back to shareholders.



For investors comfortable with the inherent volatility of shipping, TORM represents one of the most attractive ways to own high-yielding hard assets at close to book value.

Under the Radar: Forgotten Dividend Powerhouses Are Hiding in EuropeUnder the Radar:

While Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) has struggled in recent months to show demand for<a href="https://www.benzinga.com/markets/tech/25/08/47369160/tesla-model-y-in-trouble-in-china-sales-data-show-rival-quickly-taking-over" target="_blank" rel="noopener"> its electric vehicles </a>around the world, CEO Elon Musk isn't worried, with a focus on other company segments to drive future growth.



<h2 class="wp-block-heading">Optimus To The Rescue</h2>



While electric vehicles remain a key focus for Musk and Tesla, attention is shifting towards autonomous vehicles and the company's upcoming<a href="https://www.benzinga.com/news/24/06/39327644/tesla-ceo-elon-musk-eyes-25-trillion-market-cap-with-optimus-bot-admits-to-being-pathologically-opti"> Optimus humanoid robot.</a>



In Musk's race to make Tesla the most valuable company in the world, the CEO recently hinted at just how much Optimus could be worth to his company in the future.



Replying to a user on X, Musk said scaling FSD and Optimus are "the biggest factors" in Tesla achieving its Master Plan Part 4.



"80% of Tesla's value will be Optimus," Musk <a href="https://x.com/elonmusk/status/1962618811141812475">tweeted</a>.



Currently valued at $1.06 trillion and trailing market leader Nvidia Corporation ($4.09 trillion), Musk has said previously that Tesla could hit a future valuation of $25 trillion.



With the call-out of 80% of the company's value, Musk is placing a valuation of around $20 trillion for Optimus.



After the company's second-quarter financial results, Musk said Optimus&#8217; three prototypes are likely to be available by the end of 2025, with scaled production of Optimus coming in 2026.



Musk said the company would try to get to his annual production goal of one million units "as fast as it's humanly possible." Within five years, Musk sees 100,000 Optimus units being produced annually.



Speaking virtually at the X Takeover event in July, Musk said a $25 trillion market capitalization is possible thanks to robotaxis and robots.



&#8220;I think that&#8217;s probably correct if we execute well on autonomous transport and Optimus,&#8221; Musk&nbsp;<a href="https://x.com/teslaownersSV/status/1949684932491849832" target="_blank" rel="noreferrer noopener">said</a>.



In June 2024, Musk also said Optimus could help Tesla hit a $25 trillion market capitalization.



Read Also: <a href="https://www.benzinga.com/markets/equities/25/05/45536080/elon-musk-says-teslas-optimus-can-learn-tasks-by-watching-youtube-videos-just-like-a-human">Elon Musk Says Tesla&#8217;s Optimus Can Learn Tasks By Watching YouTube Videos Just Like A Human</a>



<h2 class="wp-block-heading">Optimus in the Future</h2>



During his interview at the X Takeover, Musk <a href="https://x.com/teslaownersSV/status/1949684495994749428" target="_blank" rel="noreferrer noopener">said&nbsp;</a>Optimus could be life-changing for a lot of people.



&#8220;Optimus could be like a 24-hour day nurse or helper to someone who&#8217;s paraplegic or needs physical help.&#8221;



Musk said Optimus could also be used in situations where the work is dangerous or there are a lot of repetitive tasks.



The Tesla CEO isn't the only person with big hopes or financial targets for Optimus. Nvidia CEO Jensen Huang said Optimus <a href="https://www.benzinga.com/media/25/05/45664231/teslas-optimus-may-be-the-first-humanoid-robot-to-achieve-high-volume-and-tech-scale-says-nvidia-ceo-jensen-huang-likely-to-be-the-next-multi-trillion-dollar-industry">could be the first </a>humanoid robot to reach high production volume and scale.



"I think this is likely to be the next multi-trillion-dollar industry," Huang told Bloomberg.



RBC Capital analyst Tom Narayan <a href="https://www.benzinga.com/analyst-stock-ratings/analyst-color/25/07/46695059/tesla-valuation-could-far-exceed-current-levels-analyst-sees-2-segments-driving-most-upside-and-its-not-cars">has emphasized </a>the future value of Tesla coming from robotaxis, FSD and humanoid robots.



Narayan has an Overweight rating and price target of $325 on Tesla.



In a recent investor note, Narayan factored in a global valuation for the Optimus Bot into a sum-of-the-parts valuation.



&#8220;Humanoid robots could be significant," Narayan said.



Narayan's estimate includes Optimus being used for manufacturing jobs, while the analyst also notes there are future uses for the humanoid bots.



&#8220;The reality is should these be used for home/retail purposes, the potential upside could be far greater than any other Tesla business.&#8221;



Narayan put a base value of $36.6 billion for humanoid robots in the short term, while saying this could be conservative.



Analysts are likely to increase their valuations for the Optimus segment as the robot gets close to full scale production.



Musk remains extremely optimistic on the future of robots and his latest tweet helps investors quantify the opportunity.



<h2 class="wp-block-heading">Tesla Stock Price Action</h2>



Tesla stock is down 1.4% to $329.30 on Tuesday versus a 52-week trading range of $209.64 to $488.54. Tesla stock is down 13.2% year-to-date in 2025.



Read Next: 



<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/tech/25/06/45741571/elon-musk-weighs-in-on-how-much-power-humanoid-robots-would-require-amid-teslas-optimus-push">Elon Musk Weighs In On How Much Power Humanoid Robots Would Require Amid Tesla&#8217;s Optimus Push</a></li>
</ul>



Photo: Around the World Photos/Shutterstock

Tesla's $20 Trillion Secret? Musk Says Robots Could Be 80% Of Its Value

Uber Technologies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UBER#NYSE">UBER</a>) shares are <a target="_blank" href="https://www.benzinga.com/pressreleases/25/09/b47445889/uber-eats-and-best-buy-team-up-to-deliver-tech-and-electronics-nationwide" rel="noreferrer noopener">trading lower on Tuesday.</a>



The firm said it has teamed up with Best Buy Co. Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BBY#NYSE">BBY</a>) to bring same-day delivery of electronics and small appliances to the Uber Eats app from over 800 Best Buy locations nationwide.



The partnership adds Best Buy's assortment—laptops, gaming equipment, headphones, chargers and countertop appliances—to Uber Eats for rapid delivery or scheduled drop-offs.



Also Read: <a href="https://www.benzinga.com/markets/equities/25/09/47455572/whats-going-on-with-signet-jewelers-stock-today-2" target="_blank" rel="noreferrer noopener">What&#8217;s Going On With Signet Jewelers Stock Today?</a>



Customers can place orders in the app and receive doorstep delivery, expanding Uber's push beyond restaurants and groceries into big-box retail.



Uber is deepening its retail footprint to drive order frequency and membership value, while Best Buy gains another last-mile channel that meets shoppers' expectations for fast fulfillment.



"Consumers today expect everything from groceries to gadgets to arrive at their doorsteps quickly and reliably," said Hashim Amin, Uber's head of grocery and retail for North America.



Amin added that the tie-up brings Best Buy's trusted tech selection into the on-demand economy.



The move extends Uber's retail marketplace strategy as competition intensifies among delivery platforms to capture everyday purchases beyond meals.



For Best Buy, it complements in-house options like curbside pickup and ship-from-store with a third-party channel aimed at speed and convenience.



Price Action: UBER shares are trading lower by 1.07% to $92.75 at last check Tuesday. BBY shares are trading lower by 0.94% to $72.95.



Read Next:



<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/movers/25/09/47455666/rigetti-computing-partners-with-indias-c-dac-to-scale-quantum-computing-technologies" target="_blank" rel="noreferrer noopener">Rigetti Computing Partners With India&#8217;s C-DAC To Scale Quantum Computing Technologies</a></li>
</ul>



Image: Shutterstock

Deep Dive Into Pinnacle Finl Partners Stock: Analyst Perspectives (14 Ratings)

AGCO (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AGCO#NYSE">AGCO</a>) underwent analysis by 5 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
<table style="overflow:auto; height: 90px; display: block;">
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">4</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>

The 12-month price targets, analyzed by analysts, offer insights with an average target of $127.2, a high estimate of $137.00, and a low estimate of $115.00. Marking an increase of 7.43%, the current average surpasses the previous average price target of $118.40. 
<img src="https://www.benzinga.com/files/images/story/2025/1756836104_0.png" alt="price target chart" />

<h2>Exploring Analyst Ratings: An In-Depth Overview</h2>
The analysis of recent analyst actions sheds light on the perception of AGCO by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table style="overflow:auto; height: 90px; display: block;">
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Tami Zakaria</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$135.00</td>
<td>$137.00</td>
</tr>
<tr>
<td>Steven Fisher</td>
<td>UBS</td>
<td>Raises</td>
<td>Neutral</td>
<td>$119.00</td>
<td>$100.00</td>
</tr>
<tr>
<td>Tami Zakaria</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Overweight</td>
<td>$137.00</td>
<td>$130.00</td>
</tr>
<tr>
<td>Kristen Owen</td>
<td>Oppenheimer</td>
<td>Raises</td>
<td>Outperform</td>
<td>$115.00</td>
<td>$108.00</td>
</tr>
<tr>
<td>Tami Zakaria</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Overweight</td>
<td>$130.00</td>
<td>$117.00</td>
</tr>
</tbody>
</table>

<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to AGCO. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of AGCO compared to the broader market.</li>
<li>Price Targets: Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.</li>
</ul>
Capture valuable insights into AGCO's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/AGCO/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on AGCO analyst ratings.</a>
<h2>Unveiling the Story Behind AGCO</h2>
Agco is a global manufacturer of agricultural equipment. Its main machine brands are Fendt, Massey Ferguson, and Valtra; its initiatives in precision agriculture have been organized under the PTx umbrella following a series of acquisitions. While a global business, Agco's sales skew heavily toward Europe/Middle East, representing 50%-60% of sales and even more of operating profits. The company is trying to increase its exposure to the larger North and South American markets. Its products are available through a global dealer network, which includes over 3,000 dealer and distribution locations and reach into over 140 countries. Additionally, Agco offers retail and wholesale financing to customers through its unconsolidated joint venture with Rabobank of the Netherlands.
<h3>A Deep Dive into AGCO's Financials</h3>
Market Capitalization Analysis: Below industry benchmarks, the company's market capitalization reflects a smaller scale relative to peers. This could be attributed to factors such as growth expectations or operational capacity.
Decline in Revenue: Over the 3M period, AGCO faced challenges, resulting in a decline of approximately -18.84% in revenue growth as of 30 June, 2025. This signifies a reduction in the company's top-line earnings. When compared to others in the Industrials sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of 11.95%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): AGCO's ROE excels beyond industry benchmarks, reaching 7.89%. This signifies robust financial management and efficient use of shareholder equity capital.
Return on Assets (ROA): AGCO's ROA excels beyond industry benchmarks, reaching 2.65%. This signifies efficient management of assets and strong financial health.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.74.
<h2>Analyst Ratings: Simplified</h2>
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Where AGCO Stands With Analysts

Delek US Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DK#NYSE">DK</a>) has been analyzed by 8 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
<table style="overflow:auto; height: 90px; display: block;">
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">4</td>
<td align="right">2</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">3</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
</tbody>
</table>

Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $23.88, a high estimate of $30.00, and a low estimate of $15.00. This upward trend is apparent, with the current average reflecting a 35.53% increase from the previous average price target of $17.62.
<img src="https://www.benzinga.com/files/images/story/2025/1756836096_0.png" alt="price target chart" />

<h2>Understanding Analyst Ratings: A Comprehensive Breakdown</h2>
The perception of Delek US Hldgs by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table style="overflow:auto; height: 90px; display: block;">
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Manav Gupta</td>
<td>UBS</td>
<td>Raises</td>
<td>Neutral</td>
<td>$29.00</td>
<td>$24.00</td>
</tr>
<tr>
<td>Ryan Todd</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Neutral</td>
<td>$27.00</td>
<td>$17.00</td>
</tr>
<tr>
<td>Prashant Rao</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Neutral</td>
<td>$30.00</td>
<td>$15.00</td>
</tr>
<tr>
<td>Connor Lynagh</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Underweight</td>
<td>$19.00</td>
<td>$15.00</td>
</tr>
<tr>
<td>Justin Jenkins</td>
<td>Raymond James</td>
<td>Raises</td>
<td>Outperform</td>
<td>$28.00</td>
<td>$23.00</td>
</tr>
<tr>
<td>Paul Cheng</td>
<td>Scotiabank</td>
<td>Raises</td>
<td>Sector Perform</td>
<td>$20.00</td>
<td>$14.00</td>
</tr>
<tr>
<td>Justin Jenkins</td>
<td>Raymond James</td>
<td>Raises</td>
<td>Outperform</td>
<td>$23.00</td>
<td>$22.00</td>
</tr>
<tr>
<td>Roger Read</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Underweight</td>
<td>$15.00</td>
<td>$11.00</td>
</tr>
</tbody>
</table>

<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Delek US Hldgs. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Delek US Hldgs compared to the broader market.</li>
<li>Price Targets: Understanding forecasts, analysts offer estimates for Delek US Hldgs's future value. Examining the current and prior targets provides insight into analysts' changing expectations.</li>
</ul>
Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of Delek US Hldgs's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/DK/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Delek US Hldgs analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">you can start by tracking it here</a>.
<h2>About Delek US Hldgs</h2>
Delek US Holdings Inc is an integrated energy business focused on petroleum refining, transportation and storage; wholesale crude oil, intermediate, and refined products, and convenience stores retailing. The company owns and operates independent refineries that produce a variety of petroleum products for transportation and industrial markets in the United States. It has two segments: Refining segment and Logistics segment. The logistics segment generates revenue through gathering, transporting, and storing crude oil and intermediate products, as well as by marketing, storing, and distributing refined products. The company also offers a collection of retail fuel and convenience stores operating in the Southeast region of the United States.
<h3>Delek US Hldgs: Delving into Financials</h3>
Market Capitalization Perspectives: The company's market capitalization falls below industry averages, signaling a relatively smaller size compared to peers. This positioning may be influenced by factors such as perceived growth potential or operational scale.
Revenue Growth: Delek US Hldgs's revenue growth over a period of 3M has faced challenges. As of 30 June, 2025, the company experienced a revenue decline of approximately -16.43%. This indicates a decrease in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Energy sector.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of -3.85%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): Delek US Hldgs's ROE is below industry averages, indicating potential challenges in efficiently utilizing equity capital. With an ROE of -117.31%, the company may face hurdles in achieving optimal financial returns.
Return on Assets (ROA): Delek US Hldgs's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of -1.53%, the company may face hurdles in achieving optimal financial performance.
Debt Management: The company faces challenges in debt management with a debt-to-equity ratio higher than the industry average. With a ratio of 122.58, caution is advised due to increased financial risk.
<h2>Understanding the Relevance of Analyst Ratings</h2>
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

What Analysts Are Saying About Delek US Hldgs Stock

e.l.f. Beauty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ELF#NYSE">ELF</a>) underwent analysis by 14 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
<table style="overflow:auto; height: 90px; display: block;">
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">6</td>
<td align="right">4</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">3</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>

The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $131.79, a high estimate of $150.00, and a low estimate of $112.00. This upward trend is apparent, with the current average reflecting a 11.69% increase from the previous average price target of $118.00.
<img src="https://www.benzinga.com/files/images/story/2025/1756836089_0.png" alt="price target chart" />

<h2>Interpreting Analyst Ratings: A Closer Look</h2>
In examining recent analyst actions, we gain insights into how financial experts perceive e.l.f. Beauty. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table style="overflow:auto; height: 90px; display: block;">
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Steve Powers</td>
<td>Deutsche Bank</td>
<td>Raises</td>
<td>Hold</td>
<td>$128.00</td>
<td>$121.00</td>
</tr>
<tr>
<td>Dara Mohsenian</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Overweight</td>
<td>$134.00</td>
<td>$114.00</td>
</tr>
<tr>
<td>Susan Anderson</td>
<td>Canaccord Genuity</td>
<td>Lowers</td>
<td>Buy</td>
<td>$128.00</td>
<td>$150.00</td>
</tr>
<tr>
<td>Andrea Teixeira</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$130.00</td>
<td>$132.00</td>
</tr>
<tr>
<td>Peter Grom</td>
<td>UBS</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$112.00</td>
<td>$120.00</td>
</tr>
<tr>
<td>Patty Kanada</td>
<td>Goldman Sachs</td>
<td>Raises</td>
<td>Buy</td>
<td>$137.00</td>
<td>$120.00</td>
</tr>
<tr>
<td>Dara Mohsenian</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$114.00</td>
<td>$105.00</td>
</tr>
<tr>
<td>Andrea Teixeira</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Overweight</td>
<td>$132.00</td>
<td>$123.00</td>
</tr>
<tr>
<td>Peter Grom</td>
<td>UBS</td>
<td>Raises</td>
<td>Neutral</td>
<td>$120.00</td>
<td>$95.00</td>
</tr>
<tr>
<td>Susan Anderson</td>
<td>Canaccord Genuity</td>
<td>Raises</td>
<td>Buy</td>
<td>$150.00</td>
<td>$114.00</td>
</tr>
<tr>
<td>Anna Lizzul</td>
<td>B of A Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$135.00</td>
<td>$113.00</td>
</tr>
<tr>
<td>Anna Glaessgen</td>
<td>B. Riley Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$150.00</td>
<td>$110.00</td>
</tr>
<tr>
<td>Bill Chappell</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$130.00</td>
<td>$125.00</td>
</tr>
<tr>
<td>Joel Beatty</td>
<td>Baird</td>
<td>Raises</td>
<td>Outperform</td>
<td>$145.00</td>
<td>$110.00</td>
</tr>
</tbody>
</table>

<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to e.l.f. Beauty. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of e.l.f. Beauty compared to the broader market.</li>
<li>Price Targets: Analysts gauge the dynamics of price targets, providing estimates for the future value of e.l.f. Beauty's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Capture valuable insights into e.l.f. Beauty's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/ELF/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on e.l.f. Beauty analyst ratings.</a>
<h2>Get to Know e.l.f. Beauty Better</h2>
e.l.f. Beauty Inc is a multi-brand beauty company that offers inclusive, accessible, clean, vegan, and cruelty-free cosmetics and skin care products. The Company's mission is to make beauty accessible to every eye, lip, face, and skin concern. The company offers cosmetic accessories for women, which include eyeliner, mascara, false eyelashes, lipstick, foundation for the face, moisturizer, cleanser, and other tools through its stores and e-commerce channels.
<h3>Key Indicators: e.l.f. Beauty's Financial Health</h3>
Market Capitalization: Positioned above industry average, the company's market capitalization underscores its superiority in size, indicative of a strong market presence.
Positive Revenue Trend: Examining e.l.f. Beauty's financials over 3M reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 9.02% as of 30 June, 2025, showcasing a substantial increase in top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Consumer Staples sector.
Net Margin: e.l.f. Beauty's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 9.42% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of 4.26%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): e.l.f. Beauty's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 2.6% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: e.l.f. Beauty's debt-to-equity ratio is below the industry average. With a ratio of 0.39, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
<h2>How Are Analyst Ratings Determined?</h2>
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

e.l.f. Beauty Stock: A Deep Dive Into Analyst Perspectives (14 Ratings)

Inspire Medical Systems (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/INSP#NYSE">INSP</a>) underwent analysis by 14 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
<table style="overflow:auto; height: 90px; display: block;">
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">2</td>
<td align="right">5</td>
<td align="right">7</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">6</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>

Insights from analysts' 12-month price targets are revealed, presenting an average target of $148.36, a high estimate of $230.00, and a low estimate of $97.00. Highlighting a 25.21% decrease, the current average has fallen from the previous average price target of $198.38. 
<img src="https://www.benzinga.com/files/images/story/2025/1756836079_0.png" alt="price target chart" />

<h2>Investigating Analyst Ratings: An Elaborate Study</h2>
An in-depth analysis of recent analyst actions unveils how financial experts perceive Inspire Medical Systems. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table style="overflow:auto; height: 90px; display: block;">
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Daniel Markowitz</td>
<td>Evercore ISI Group</td>
<td>Announces</td>
<td>Outperform</td>
<td>$150.00</td>
<td>-</td>
</tr>
<tr>
<td>Mike Kratky</td>
<td>Leerink Partners</td>
<td>Lowers</td>
<td>Market Perform</td>
<td>$97.00</td>
<td>$116.00</td>
</tr>
<tr>
<td>Mike Kratky</td>
<td>Leerink Partners</td>
<td>Lowers</td>
<td>Market Perform</td>
<td>$116.00</td>
<td>$149.00</td>
</tr>
<tr>
<td>Richard Newitter</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Hold</td>
<td>$125.00</td>
<td>$190.00</td>
</tr>
<tr>
<td>Frank Takkinen</td>
<td>Lake Street</td>
<td>Lowers</td>
<td>Buy</td>
<td>$150.00</td>
<td>$270.00</td>
</tr>
<tr>
<td>Larry Biegelsen</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$101.00</td>
<td>$174.00</td>
</tr>
<tr>
<td>Danielle Antalffy</td>
<td>UBS</td>
<td>Lowers</td>
<td>Buy</td>
<td>$230.00</td>
<td>$270.00</td>
</tr>
<tr>
<td>Shagun Singh</td>
<td>RBC Capital</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$180.00</td>
<td>$215.00</td>
</tr>
<tr>
<td>Jonathan Block</td>
<td>Stifel</td>
<td>Lowers</td>
<td>Hold</td>
<td>$140.00</td>
<td>$175.00</td>
</tr>
<tr>
<td>Adam Maeder</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$150.00</td>
<td>$233.00</td>
</tr>
<tr>
<td>Robbie Marcus</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$110.00</td>
<td>$195.00</td>
</tr>
<tr>
<td>Brett Fishbin</td>
<td>Keybanc</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$197.00</td>
<td>$216.00</td>
</tr>
<tr>
<td>Kallum Titchmarsh</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$182.00</td>
<td>$200.00</td>
</tr>
<tr>
<td>Mike Kratky</td>
<td>Leerink Partners</td>
<td>Lowers</td>
<td>Market Perform</td>
<td>$149.00</td>
<td>$176.00</td>
</tr>
</tbody>
</table>

<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Inspire Medical Systems. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of Inspire Medical Systems compared to the broader market.</li>
<li>Price Targets: Analysts predict movements in price targets, offering estimates for Inspire Medical Systems's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
For valuable insights into Inspire Medical Systems's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/INSP/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Inspire Medical Systems analyst ratings.</a>
<h2>Discovering Inspire Medical Systems: A Closer Look</h2>
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States.
<h3>Inspire Medical Systems: Delving into Financials</h3>
Market Capitalization Analysis: Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity.
Positive Revenue Trend: Examining Inspire Medical Systems's financials over 3M reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 10.82% as of 30 June, 2025, showcasing a substantial increase in top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Health Care sector.
Net Margin: Inspire Medical Systems's net margin excels beyond industry benchmarks, reaching -1.65%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): Inspire Medical Systems's ROE stands out, surpassing industry averages. With an impressive ROE of -0.55%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): The company's ROA is below industry benchmarks, signaling potential difficulties in efficiently utilizing assets. With an ROA of -0.47%, the company may need to address challenges in generating satisfactory returns from its assets.
Debt Management: With a below-average debt-to-equity ratio of 0.05, Inspire Medical Systems adopts a prudent financial strategy, indicating a balanced approach to debt management.
<h2>Analyst Ratings: What Are They?</h2>
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Where Inspire Medical Systems Stands With Analysts

12 analysts have shared their evaluations of DoubleVerify Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DV#NYSE">DV</a>) during the recent three months, expressing a mix of bullish and bearish perspectives.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
<table style="overflow:auto; height: 90px; display: block;">
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">4</td>
<td align="right">6</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">4</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
</tbody>
</table>

In the assessment of 12-month price targets, analysts unveil insights for DoubleVerify Holdings, presenting an average target of $19.75, a high estimate of $27.00, and a low estimate of $13.00. Surpassing the previous average price target of $19.00, the current average has increased by 3.95%.
<img src="https://www.benzinga.com/files/images/story/2025/1756836071_0.png" alt="price target chart" />

<h2>Understanding Analyst Ratings: A Comprehensive Breakdown</h2>
An in-depth analysis of recent analyst actions unveils how financial experts perceive DoubleVerify Holdings. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table style="overflow:auto; height: 90px; display: block;">
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Matthew Condon</td>
<td>JMP Securities</td>
<td>Maintains</td>
<td>Market Outperform</td>
<td>$20.00</td>
<td>$20.00</td>
</tr>
<tr>
<td>Matthew Cost</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$18.00</td>
<td>$17.00</td>
</tr>
<tr>
<td>Raimo Lenschow</td>
<td>Barclays</td>
<td>Raises</td>
<td>Overweight</td>
<td>$18.00</td>
<td>$16.00</td>
</tr>
<tr>
<td>Brian Pitz</td>
<td>BMO Capital</td>
<td>Raises</td>
<td>Outperform</td>
<td>$27.00</td>
<td>$26.00</td>
</tr>
<tr>
<td>Mark Murphy</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Overweight</td>
<td>$19.00</td>
<td>$18.00</td>
</tr>
<tr>
<td>Laura Martin</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$18.00</td>
<td>$18.00</td>
</tr>
<tr>
<td>Youssef Squali</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$22.00</td>
<td>$21.00</td>
</tr>
<tr>
<td>Brian Pitz</td>
<td>BMO Capital</td>
<td>Raises</td>
<td>Outperform</td>
<td>$26.00</td>
<td>$25.00</td>
</tr>
<tr>
<td>Andrew Boone</td>
<td>JMP Securities</td>
<td>Maintains</td>
<td>Market Outperform</td>
<td>$20.00</td>
<td>$20.00</td>
</tr>
<tr>
<td>Mark Kelley</td>
<td>Stifel</td>
<td>Raises</td>
<td>Buy</td>
<td>$18.00</td>
<td>$17.00</td>
</tr>
<tr>
<td>Alec Brondolo</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Underweight</td>
<td>$13.00</td>
<td>$12.00</td>
</tr>
<tr>
<td>Laura Martin</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$18.00</td>
<td>$18.00</td>
</tr>
</tbody>
</table>

<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to DoubleVerify Holdings. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of DoubleVerify Holdings compared to the broader market.</li>
<li>Price Targets: Delving into movements, analysts provide estimates for the future value of DoubleVerify Holdings's stock. This analysis reveals shifts in analysts' expectations over time.</li>
</ul>
Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of DoubleVerify Holdings's market position. Stay informed and make well-informed decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/DV/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on DoubleVerify Holdings analyst ratings.</a>
<h2>About DoubleVerify Holdings</h2>
DoubleVerify Holdings Inc is a digital media measurement and analytics software platform. Its solutions provide advertisers with unbiased data analytics that enable them to increase the effectiveness, quality, and return on their digital advertising investments. Its DV Authentic Ad, a proprietary metric of digital media quality, measures whether a digital ad was delivered in a brand-suitable environment, fully viewable, by a real person, and in the intended geography. The company's software interface, DV Pinnacle, delivers these metrics to customers in real time, allowing them to access critical performance data on their digital transactions. Geographically, the company operates in the United States and also has a presence in Germany, Singapore, France, Canada, Japan, and other countries.
<h3>DoubleVerify Holdings's Financial Performance</h3>
Market Capitalization: Indicating a reduced size compared to industry averages, the company's market capitalization poses unique challenges.
Revenue Growth: DoubleVerify Holdings's revenue growth over a period of 3M has been noteworthy. As of 30 June, 2025, the company achieved a revenue growth rate of approximately 21.25%. This indicates a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Communication Services sector.
Net Margin: DoubleVerify Holdings's net margin is impressive, surpassing industry averages. With a net margin of 4.63%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): DoubleVerify Holdings's ROE stands out, surpassing industry averages. With an impressive ROE of 0.83%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): DoubleVerify Holdings's ROA stands out, surpassing industry averages. With an impressive ROA of 0.69%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: DoubleVerify Holdings's debt-to-equity ratio is below the industry average. With a ratio of 0.1, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
<h2>The Core of Analyst Ratings: What Every Investor Should Know</h2>
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Demystifying DoubleVerify Holdings: Insights From 12 Analyst Reviews

Investors with a lot of money to spend have taken a bullish stance on Datadog (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DDOG#NASDAQ">DDOG</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with DDOG, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://www.benzinga.com/pro/">Benzinga</a>'s options scanner spotted 16 uncommon options trades for Datadog.
This isn't normal.
The overall sentiment of these big-money traders is split between 50% bullish and 43%, bearish.
Out of all of the special options we uncovered, 3 are puts, for a total amount of $100,385, and 13 are calls, for a total amount of $957,863.
<h3>What's The Price Target?</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $55.0 to $165.0 for Datadog over the recent three months. 
<h3>Volume &amp; Open Interest Development</h3>
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Datadog's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Datadog's substantial trades, within a strike price spectrum from $55.0 to $165.0 over the preceding 30 days.
<h3>Datadog Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1756836045_0.png" alt="Options Call Chart" />

<h3>Noteworthy Options Activity:</h3>
<table style="overflow:auto; height: 90px; display: block;">
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>DDOG</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>09/05/25</td>
<td>$1.69</td>
<td>$1.44</td>
<td>$1.55</td>
<td>$135.00</td>
<td>$387.5K</td>
<td>3.9K</td>
<td>2.6K</td>
</tr>
<tr>
<td>DDOG</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>11/21/25</td>
<td>$2.32</td>
<td>$2.08</td>
<td>$2.15</td>
<td>$165.00</td>
<td>$103.2K</td>
<td>407</td>
<td>481</td>
</tr>
<tr>
<td>DDOG</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>10/17/25</td>
<td>$6.8</td>
<td>$3.95</td>
<td>$4.84</td>
<td>$140.00</td>
<td>$83.4K</td>
<td>3.2K</td>
<td>0</td>
</tr>
<tr>
<td>DDOG</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>09/19/25</td>
<td>$44.15</td>
<td>$43.9</td>
<td>$44.15</td>
<td>$90.00</td>
<td>$61.8K</td>
<td>220</td>
<td>14</td>
</tr>
<tr>
<td>DDOG</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>11/21/25</td>
<td>$2.19</td>
<td>$2.09</td>
<td>$2.15</td>
<td>$165.00</td>
<td>$51.6K</td>
<td>407</td>
<td>241</td>
</tr>
</tbody>
</table>
<h3>About Datadog</h3>
Datadog is a cloud-native company that focuses on analyzing machine data. The firm's product portfolio, delivered via software as a service, allows a client to monitor and analyze its entire IT infrastructure. Datadog's platform can ingest and analyze large amounts of machine-generated data in real time, allowing clients to utilize it for a variety of applications throughout their businesses.
In light of the recent options history for Datadog, it's now appropriate to focus on the company itself. We aim to explore its current performance.
<h3>Current Position of Datadog</h3>
<ul>
<li>Currently trading with a volume of 2,750,036, the DDOG's price is down by -1.61%, now at $134.48. </li>
<li>RSI readings suggest the stock is currently may be approaching overbought.</li>
<li>Anticipated earnings release is in 65 days.</li>
</ul>
<h3>Expert Opinions on Datadog</h3>
Over the past month, 5 industry analysts have shared their insights on this stock, proposing an average target price of $167.8.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>.
&#x2A; An analyst from Citigroup persists with their Buy rating on Datadog, maintaining a target price of $170. 
&#x2A; An analyst from Needham downgraded its action to Buy with a price target of $175. 
&#x2A; An analyst from Jefferies has decided to maintain their Buy rating on Datadog, which currently sits at a price target of $160. 
&#x2A; An analyst from Mizuho persists with their Outperform rating on Datadog, maintaining a target price of $155. 
&#x2A; An analyst from Cantor Fitzgerald persists with their Overweight rating on Datadog, maintaining a target price of $179. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Datadog, <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> gives you real-time options trades alerts.